1 / 29

Respiratory Failure

Respiratory Failure. Dr Svitlana Zhelezna Clinical Teaching Fellow UHCW NHS Trust svitlana.zhelezna@uhcw.nhs.uk 2013/2014 academic year. Learning objectives:. Describe the clinical features, potential causes and management of respiratory failure

debra-mcintosh
Télécharger la présentation

Respiratory Failure

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Respiratory Failure Dr Svitlana Zhelezna Clinical Teaching Fellow UHCW NHS Trust svitlana.zhelezna@uhcw.nhs.uk 2013/2014 academic year

  2. Learning objectives: • Describe the clinical features, potential causes and management of respiratory failure • List indications/contraindications/complications of non invasive ventilation and understand its set up and monitoring

  3. Definition: Acute respiratory failure occurs when pulmonary system is no longer able to meet the metabolic demands of the body

  4. Type 1 Respiratory Failure Hypoxaemic pO2 < 8 kPa ON AIR pCO2 <6.0 kPa Type 2 Respiratory Failure Hypercapnic pO2 < 8 kPa ON AIR pCO2 > 6.0 kPa

  5. 1. Respiratory compensation Tachypnoea Accessory muscles Recession Nasal flaring 2. Sympathetic stimulation HR BP (early) sweating 3. Tissue hypoxia Altered mental state HR and BP (late) 4. Haemoglobin desaturation: (SpO2 < 90%) Clinical signs:

  6. Case 1 • 70 year old man referred to A&E by his GP • PC: SOB and productive cough 4/7 • HPC: gradual onset over 4-6/12 but worse over the last 3-4 days. • SH: smoking 30 pack years. • O/E: O2 sats are 91% on air, RR 26, temp 37.8, BP 130/75, HR 89. Pt’s chest shows widespread bilateral wheeze throughout, reduced air entry LLL. 1. List your differential diagnosis and investigation tests. 2. What would be your initial management of this patient?

  7. ABG: pH 7.31 pO2 8.4 kPa (on 6L O2) pCO2 5.9 kPa, HCO3- 21 mmol/l Lac 3.1 What is your interpretation?

  8. Investigations: ABG FBC, U&E, LFTs Peak flow CXR ECG Sputum and Blood culture Urine dip, Urine Microscopy Treatment: A-E - Sepsis! Oxygen – high flow initially, consider controlled to aim O2Sat 88-92% when stable Nebulised bronchodilators Steroids Antibiotics (sepsis six pathway) Initial management:

  9. COPD – Background: • Definition: COPD is predominantly caused by smoking and is characterised by airflow obstruction that: is not fully reversible and is usually progressive in the long term • COPD acute exacerbations: Increasing dyspnoea Increasing sputum volume Increasing sputum purulence (change in character)

  10. Differentiating COPD from asthma

  11. Asthma – Background: More than one of the following symptoms: • Wheeze, cough, difficulty breathing, frequent and recurrent chest tightness, worse at night and in the early morning; • Occur in response to, or are worse after, exercise or other triggers, • Personal/ Family history of atopic disorder and/or asthma • Widespread wheeze heard on auscultation • History of improvement in symptoms or lung function in response to adequate therapy.

  12. LIFE THREATENING PEF <33% best or predicted SpO2 <92% PaO2 <8 kPa normal PaCO2 (4.6-6.0 kPa) silent chest cyanosis poor respiratory effort arrhythmia exhaustion, altered conscious level NEAR FATAL Raised PaCO2 and/or requiring mechanical ventilation with raised inflation pressures Severe Asthma

  13. Criteria for Referral to ITU Refer any patient: • requiring ventilatory support • with acute severe or life threatening asthma, • failing to respond to therapy, evidenced by: - deteriorating PEF - persisting or worsening hypoxia - hypercapnea - ABG analysis showing low pH - exhaustion, feeble respiration - drowsiness, confusion, altered conscious state - respiratory arrest

  14. Case 2 • 17 y.o. female student • PC: severe SOB, can not speak in full sentences • HPC: woke up at 4 am feeling SOB and started coughing, her housemate called ambulance • PMH: too breathless to give • O/E: Pt agitated, wide spread audible wheeze bilaterally, poor chest expansion, using accessory muscles, HR 100, BP 130/85, T 36,6, O2 sat 93% What would be your differential diagnosis and initial management?

  15. ABG: pH 7.33 pO2 8.2 kPa (on 15L O2) pCO2 2.8 kPa, HCO3- 18 mmol/l What is your interpretation?

  16. Initial Management Oxygen – high flow 15L Nebulised bronchodilators Peak flow ABG FBC, U&E, LFTs, Steroids

  17. Case 3 • 76 year old male • PC: SOB, 7/7 productive cough with phlegm • PMH: known COPD, LTOT at home 2L for 16/24. • On admission: RR 18, sats 85% on 2L oxygen, HR 110, BP 134/68, temp 38.5. RLL crackles, but widespread wheeze throughout both lung fields. • The paramedics gave him 5ml salbutamol nebs and 100mg IV hydrocortisone an hour ago, he was given IV abx first dose, but he is not improving as yet, but become drowsy

  18. What would be your management?

  19. What next? • Continue Nebulised Salbutamol • NIV (non-invasive ventilation)

  20. NIV – non-invasive ventilation • Definition: NIV is the delivery of mechanical ventilation to the lungs using techniques that do not require an endotracheal airway

  21. Medical conditions/Indications: • Acute exacerbation of COPD (pH 7.26 – 7.35 or patients with NIV as ceiling of care and considered not suitable for HDU/ITU care) • Morbid Obesity / Severe OSA / Alveolar Hypoventilation Syndrome • Chronic Neuromuscular Disease • Kyphoscoliosis / Chest wall deformity.

  22. NIV contraindications: • Respiratory arrest • Undrained pneumothorax • Impaired consciousness/confusion/aggressive behaviour • Chest wall trauma • Uncontrolled vomiting/distended abdomen/ excessive secretions • Facial trauma/surgery, burns or facial abnormalities that are likely to cause difficulty with appropriate mask fit. • Recent upper abdominal surgery or intestinal obstruction.

  23. Starting NIV: • Locations: HDU/ITU, Respiratory ward A+E resus (Not usually on a general ward – the nursing staff will not know how to deal with it) • Settings: • IPAP start at 10cm H20 • EPAP start at 5 cm H20 • Backup rate of 8 breaths per minute (Most patients tolerate these settings)

  24. Monitoring NIV: • Main actions: • Baseline ABG, RR, HR • Repeat ABG after one hour of starting • After every setting change, repeat ABG at 1 hour • Otherwise, every 4 hours, or if not well • Key points: • Aim minimum 6 hours treatment • Most people better by 24 hours on NIV • Weaning thereafter

  25. Complications of NIV: • Increased IPAP – pneumothorax, • Decreased pre-load – may drop BP • Increased risk of aspiration • Face mask discomfort • Anxiety + confusion

  26. Key message Common contributors to RF • Type 1 (↓O2): Asthma and COPD • Type 2 (↓O2 and ↑CO2): COPD and life threatening asthma NIV • is effective in treating ↑CO2

  27. Summary • worry if • RR > 30/min (or < 8/min) • unable to speak 1/2 sentence without pausing • agitated, confused or comatose • cyanosed or SpO2 < 90% • deteriorating despite therapy • remember • normal SpO2 does not mean severe ventilatory problems are not present

  28. Thank you! Any questions?

More Related